Multispectral imaging and pathology: Seeing and doing more

Richard M Levenson, Alessandro Fornari, Massimo Loda

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Background: The current appreciation of the biological complexity of disease has led to increasing demands on pathologists to provide clinically relevant, quantitative morphological and molecular information while preserving cellular and tissue context. This can be technically challenging, especially when signals of interest are colocalized. With fluorescence-based methods, sensitivity and quantitative reliability may be compromised by spectral cross-talk between labels and by autofluorescence. In brightfield microscopy, over lapping chromogenic signals pose similar imaging difficulties. Approach: These challenges can be addressed using commercially available multispectral imaging technologies attached to standard microscope platforms, or alternatively, integrated into whole-slide scanning instruments. Assessment: Multispectral techniques, along with other developments in digital analysis, will allow pathologists to deliver appropriate quantitative and multiplexed analyses in a reproducible and timely manner. Caveats apply- as the complexity of the sample preparation and analysis components increases, commensurate attention must be paid to the use of appropriate controls for all stages of the process.

Original languageEnglish (US)
Pages (from-to)1067-1081
Number of pages15
JournalExpert Opinion on Medical Diagnostics
Volume2
Issue number9
DOIs
StatePublished - Sep 2008
Externally publishedYes

Fingerprint

Pathology
Chromogenics
Imaging techniques
Lapping
Labels
Microscopy
Microscopic examination
Microscopes
Fluorescence
Tissue
Technology
Scanning
Pathologists

Keywords

  • Image analysis
  • Immunofluorescence
  • Immunohistochemistry
  • Machine-vision
  • Multispectral imaging
  • Oncology
  • Pathology
  • Personalized medicine
  • Segmentation

ASJC Scopus subject areas

  • Biomedical Engineering
  • Medicine(all)
  • Biochemistry, medical
  • Molecular Medicine

Cite this

Multispectral imaging and pathology : Seeing and doing more. / Levenson, Richard M; Fornari, Alessandro; Loda, Massimo.

In: Expert Opinion on Medical Diagnostics, Vol. 2, No. 9, 09.2008, p. 1067-1081.

Research output: Contribution to journalArticle

Levenson, Richard M ; Fornari, Alessandro ; Loda, Massimo. / Multispectral imaging and pathology : Seeing and doing more. In: Expert Opinion on Medical Diagnostics. 2008 ; Vol. 2, No. 9. pp. 1067-1081.
@article{4502deae510040e2aa50d52bd7dddb56,
title = "Multispectral imaging and pathology: Seeing and doing more",
abstract = "Background: The current appreciation of the biological complexity of disease has led to increasing demands on pathologists to provide clinically relevant, quantitative morphological and molecular information while preserving cellular and tissue context. This can be technically challenging, especially when signals of interest are colocalized. With fluorescence-based methods, sensitivity and quantitative reliability may be compromised by spectral cross-talk between labels and by autofluorescence. In brightfield microscopy, over lapping chromogenic signals pose similar imaging difficulties. Approach: These challenges can be addressed using commercially available multispectral imaging technologies attached to standard microscope platforms, or alternatively, integrated into whole-slide scanning instruments. Assessment: Multispectral techniques, along with other developments in digital analysis, will allow pathologists to deliver appropriate quantitative and multiplexed analyses in a reproducible and timely manner. Caveats apply- as the complexity of the sample preparation and analysis components increases, commensurate attention must be paid to the use of appropriate controls for all stages of the process.",
keywords = "Image analysis, Immunofluorescence, Immunohistochemistry, Machine-vision, Multispectral imaging, Oncology, Pathology, Personalized medicine, Segmentation",
author = "Levenson, {Richard M} and Alessandro Fornari and Massimo Loda",
year = "2008",
month = "9",
doi = "10.1517/17530059.2.9.1067",
language = "English (US)",
volume = "2",
pages = "1067--1081",
journal = "Expert Opinion on Medical Diagnostics",
issn = "1753-0059",
publisher = "Informa Healthcare",
number = "9",

}

TY - JOUR

T1 - Multispectral imaging and pathology

T2 - Seeing and doing more

AU - Levenson, Richard M

AU - Fornari, Alessandro

AU - Loda, Massimo

PY - 2008/9

Y1 - 2008/9

N2 - Background: The current appreciation of the biological complexity of disease has led to increasing demands on pathologists to provide clinically relevant, quantitative morphological and molecular information while preserving cellular and tissue context. This can be technically challenging, especially when signals of interest are colocalized. With fluorescence-based methods, sensitivity and quantitative reliability may be compromised by spectral cross-talk between labels and by autofluorescence. In brightfield microscopy, over lapping chromogenic signals pose similar imaging difficulties. Approach: These challenges can be addressed using commercially available multispectral imaging technologies attached to standard microscope platforms, or alternatively, integrated into whole-slide scanning instruments. Assessment: Multispectral techniques, along with other developments in digital analysis, will allow pathologists to deliver appropriate quantitative and multiplexed analyses in a reproducible and timely manner. Caveats apply- as the complexity of the sample preparation and analysis components increases, commensurate attention must be paid to the use of appropriate controls for all stages of the process.

AB - Background: The current appreciation of the biological complexity of disease has led to increasing demands on pathologists to provide clinically relevant, quantitative morphological and molecular information while preserving cellular and tissue context. This can be technically challenging, especially when signals of interest are colocalized. With fluorescence-based methods, sensitivity and quantitative reliability may be compromised by spectral cross-talk between labels and by autofluorescence. In brightfield microscopy, over lapping chromogenic signals pose similar imaging difficulties. Approach: These challenges can be addressed using commercially available multispectral imaging technologies attached to standard microscope platforms, or alternatively, integrated into whole-slide scanning instruments. Assessment: Multispectral techniques, along with other developments in digital analysis, will allow pathologists to deliver appropriate quantitative and multiplexed analyses in a reproducible and timely manner. Caveats apply- as the complexity of the sample preparation and analysis components increases, commensurate attention must be paid to the use of appropriate controls for all stages of the process.

KW - Image analysis

KW - Immunofluorescence

KW - Immunohistochemistry

KW - Machine-vision

KW - Multispectral imaging

KW - Oncology

KW - Pathology

KW - Personalized medicine

KW - Segmentation

UR - http://www.scopus.com/inward/record.url?scp=77953388970&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953388970&partnerID=8YFLogxK

U2 - 10.1517/17530059.2.9.1067

DO - 10.1517/17530059.2.9.1067

M3 - Article

C2 - 23495926

AN - SCOPUS:77953388970

VL - 2

SP - 1067

EP - 1081

JO - Expert Opinion on Medical Diagnostics

JF - Expert Opinion on Medical Diagnostics

SN - 1753-0059

IS - 9

ER -